Developed by Shray Alag, The Harker School
Sections: Correlations,
Clinical Trials, and HPO
Navigate: Clinical Trials and HPO
Navigate: Correlations HPO
There is one clinical trial.
This will be a prospective, multi-arm, randomized, and non-blinded clinical trial designed to evaluate the performance, comfort, and usability of the Toffee full face mask amongst participants who have been prescribed PAP therapy by a physician. This clinical trial will take place across three investigation sites with a sample of 45 participants.
Description: To assess the comfort of the mask as experienced by the participant. Comfort will be measured on a 5 point likert type scale from Very Uncomfortable to Very Comfortable. Different aspects of the mask such as cushion comfort, headgear comfort and overall comfort will be assessed using the same scale. Questions will be asked on a questionnaire and further qualitative responses will be captured during an interview.
Measure: Comfort Time: Assessed 2 weeks after mask fittingDescription: To assess the ease of use of the mask as experienced by the participant. Questions regarding the ease of assembly, disassembly and mask fitting will be asked using a 5 point likert type scale with responses ranging from Very Easy to Very Difficult. Questions will be asked via a questionnaire with additional qualitative responses captured during an interview.
Measure: Usability Time: Assessed 2 weeks after mask fittingDescription: To assess the long term reliability and durability of the mask when used in a home. environment over an extended period of time. Open ended questions during a semi-structured interview will be asked to participants who will provide qualitative information on their experience using the mask with specific regard to broken or degraded parts and components.
Measure: Reliability and Durability Time: Assessed 4 months after mask fittingAlphabetical listing of all HPO terms. Navigate: Correlations Clinical Trials
Data processed on September 26, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.
Drug Reports MeSH Reports HPO Reports